Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2720
Gene Symbol: GLB1
GLB1
0.010 Biomarker group BEFREE β-Galactosidase and α-galactosidase activities exhibited a statistically significant negative correlation with age in NCs, and β-hexosaminidase activity showed a positive correlation with age in PS. 30415794 2019
Entrez Id: 3064
Gene Symbol: HTT
HTT
0.010 Biomarker group BEFREE Parkinsonism with a Hint of Huntington's from 29 CAG Repeats in HTT. 31546689 2019
Entrez Id: 27306
Gene Symbol: HPGDS
HPGDS
0.010 Biomarker group BEFREE Inhibition of glutathione S-transferase-pi triggers c-jun N-terminal kinase-dependent neuronal death in Zn-induced Parkinsonism. 30076580 2019
Entrez Id: 10294
Gene Symbol: DNAJA2
DNAJA2
0.010 GeneticVariation group BEFREE DNAJC13 is one of five DNAJ 'C' class chaperone variants implicated in monogenic parkinsonism. 31082451 2019
Entrez Id: 9306
Gene Symbol: SOCS6
SOCS6
0.010 Biomarker group BEFREE Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism. 30875335 2019
Entrez Id: 7384
Gene Symbol: UQCRC1
UQCRC1
0.010 GeneticVariation group BEFREE A novel missense mutation in the UQCRC1 gene was found in a family with autosomal-dominant inheritance parkinsonism via whole-exome sequencing analysis. 30788857 2019
Entrez Id: 6855
Gene Symbol: SYP
SYP
0.010 AlteredExpression group BEFREE We tested whether DHA in vivo exerts a neuroprotective effect on rotenone-induced parkinsonism and explored the mechanisms involved, including mitochondrial function and ultrastructure as well as the expression of tubulin and synaptophysin. 30342962 2018
Entrez Id: 151056
Gene Symbol: PLB1
PLB1
0.010 GeneticVariation group BEFREE Arachidonic acid is released by phospholipase A2 activity and clinical observations have shown a link between mutations in PLA2G6, the gene responsible for the production of phospholipase A2, and early-onset types of parkinsonism. 29577851 2018
Entrez Id: 7019
Gene Symbol: TFAM
TFAM
0.010 Biomarker group BEFREE MitoPark mice lack the gene coding for mitochondrial transcription factor A specifically in dopamine neurons, which over time produces a progressive decline of neuronal function and related behavior that phenotypically mirrors human parkinsonism. 30440089 2018
Entrez Id: 6607
Gene Symbol: SMN2
SMN2
0.010 GeneticVariation group BEFREE There are limited electrophysiological data, however, describing how parkinsonism impacts the presupplementary motor area (pre-SMA) and SMA proper (SMAp), cortical areas known to be involved in movement planning and motor control. 29873615 2018
Entrez Id: 2914
Gene Symbol: GRM4
GRM4
0.010 Biomarker group BEFREE We studied whether a novel positive allosteric modulator of the metabotropic glutamate receptor 4, PXT002331 (foliglurax), could reduce parkinsonism in primate models. 30216534 2018
Entrez Id: 1471
Gene Symbol: CST3
CST3
0.010 Biomarker group BEFREE Although Cystatin C (Cys C) and low-density cholesterol lipoprotein-C (LDL-C) are known to play critical roles in Parkinsonism, it is unknown whether they can be used as markers to distinguish PSP patients from healthy subjects and to determine disease severity. 29574085 2018
Entrez Id: 5319
Gene Symbol: PLA2G1B
PLA2G1B
0.010 GeneticVariation group BEFREE Arachidonic acid is released by phospholipase A2 activity and clinical observations have shown a link between mutations in PLA2G6, the gene responsible for the production of phospholipase A2, and early-onset types of parkinsonism. 29577851 2018
Entrez Id: 26281
Gene Symbol: FGF20
FGF20
0.010 AlteredExpression group BEFREE Our study is the first to uncover the potential link between manganese exposure, altered miRNA expression and parkinsonism: manganese exposure causes overexpression of SNCA and FGF-20 by diminishing miR-7 and miR-433 levels. 28986288 2018
Entrez Id: 100329167
Gene Symbol: AAA1
AAA1
0.010 Biomarker group BEFREE We report a novel m-AAA-associated phenotype characterized by early-onset optic atrophy with spastic ataxia and L-dopa-responsive parkinsonism. 30252181 2018
Entrez Id: 7534
Gene Symbol: YWHAZ
YWHAZ
0.010 GeneticVariation group BEFREE Arachidonic acid is released by phospholipase A2 activity and clinical observations have shown a link between mutations in PLA2G6, the gene responsible for the production of phospholipase A2, and early-onset types of parkinsonism. 29577851 2018
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.010 Biomarker group BEFREE Syndrome of parkinsonism and ataxia is an important manifestation of CASPR2 autoimmunity where we can offer a definitive treatment. 29264691 2018
Entrez Id: 5972
Gene Symbol: REN
REN
0.010 Biomarker group BEFREE Identification of renin-angiotensin system in the interplay of hypertension and neurodegeneration has paved the way for the repurposing of antihypertensive drugs against Parkinsonism. 30350232 2018
Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
0.010 Biomarker group BEFREE Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model. 30476904 2018
Entrez Id: 6687
Gene Symbol: SPG7
SPG7
0.010 Biomarker group BEFREE SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit. 29246844 2018
Entrez Id: 8818
Gene Symbol: DPM2
DPM2
0.010 Biomarker group BEFREE SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene. 29523295 2018
Entrez Id: 4771
Gene Symbol: NF2
NF2
0.010 Biomarker group BEFREE Asymmetry in parkinsonism was associated with symptom severity on all CGI-SCH SI scales (β range, 0.37-3.74) and significantly associated with the positive symptom scale (β, 3.74; 95% CI, 0.35-7.31). 29459835 2018
Entrez Id: 9649
Gene Symbol: RALGPS1
RALGPS1
0.010 Biomarker group BEFREE SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene. 29523295 2018
Entrez Id: 10352
Gene Symbol: WARS2
WARS2
0.010 Biomarker group BEFREE This case expands the phenotypic spectrum of WARS2 deficiency and emphasizes the importance of mitochondrial protein synthesis in the pathogenesis of Parkinsonism. 29120065 2018
Entrez Id: 4810
Gene Symbol: NHS
NHS
0.010 GeneticVariation group BEFREE Using anonymized data from South London and Maudsley NHS Foundation Trust electronic health records we applied quantitative systems pharmacology, a neurophysiology-based computer model of humanized neuronal circuits, to predict the risk for parkinsonism symptoms in patients with schizophrenia prescribed two concomitant antipsychotics. 30232932 2018